15 results on '"Ross G. Everett"'
Search Results
2. Scrotoplasty
- Author
-
Ross G. Everett and Daniel D. Dugi
- Published
- 2023
- Full Text
- View/download PDF
3. Contributors
- Author
-
Cori A. Agarwal, Brandon Alba, Ashley Alford, Marko Bencic, Marta R. Bizic, Rachel Bluebond-Langner, Mark-Bram Bouman, Marci L. Bowers, Marlon Buncamper, Luis Capitán, Fermín Capitán-Cañadas, Amanda C. Chi, Karel E.Y. Claes, Wietse Claeys, Curtis Crane, Fionnuala Crowley, Ashley DeLeon, Krystal A. DePorto, Wouter B. van der Sluis, Marcelo Di Maggio, Miroslav L. Djordjevic, Daniel D. Dugi III, Esteban Elena Scarafoni, Ross G. Everett, Daisy I. Gonzalez, Aaron Grotas, Alireza Hamidian Jahromi, Dana Johns, Marissa Kent, Anish Kumar, Natasha Kyprianou, Dara J. Lundon, Wilhelmus J.H.J. Meijerink, Meredith Mihalopoulos, Kirtishri Mishra, Stan Monstrey, Shane Morrison, Gerhard S. Mundinger, Dmitriy Nikolavsky, Elizabeth O’Neill, Melissa M. Poh, Rajveer S. Purohit, Jorge Rey, Polina Reyblat, Zoe Isabel Rodriguez, Paige De Rosa, Joshua D. Safer, Christopher J. Salgado, Jessica N. Schardein, Loren Schechter, Kaylee B. Scott, Gennaro Selvaggi, Michelle Seu, Yair Shachar, Tony Shao, Alexandra R. Siegal, Daniel Simon, Joshua Sterling, Borko Stojanovic, Lindsay M. Tanner, Ann Tran, Jurriaan B. Tuynman, Aran Yoo, Lee C. Zhao, and Ariel Zisman
- Published
- 2023
- Full Text
- View/download PDF
4. Is a 50% improvement threshold adequate to justify progression from sacral neuromodulation testing to implant?
- Author
-
Zachary J. Prebay, Truman Landowski, Ross G. Everett, David K. Charles, R. Corey O'Connor, and Michael L. Guralnick
- Subjects
medicine.medical_specialty ,Univariate analysis ,030219 obstetrics & reproductive medicine ,Urinary symptoms ,business.industry ,Urology ,030232 urology & nephrology ,Urinary incontinence ,Symptom reduction ,medicine.disease ,Surgery ,03 medical and health sciences ,Subjective improvement ,0302 clinical medicine ,Sacral nerve stimulation ,Overactive bladder ,medicine ,Neurology (clinical) ,Implant ,medicine.symptom ,business - Abstract
PURPOSE A ≥50% subjective improvement in urinary symptoms during sacral neuromodulation testing (SNM-I) is currently used as the indication for progression to second-stage implantation (SNM-II). While most patients will have successful SNM-I and proceed to SNM-II, deterioration in efficacy over time has been reported. It remains unclear if the durability of efficacy is related to the initial symptom reduction. We sought to determine if the degree of improvement after SNM-I is sufficient to predict long-term success. METHODS The records of all patients who underwent sacral neuromodulation (SNM) for overactive bladder were reviewed. Subjects were divided into those who reported 50%-75% improvement (Group 1) and more than 75% improvement (Group 2) after SNM-I. Differences in clinical variables and long-term device efficacy were compared between groups. RESULTS Of 213 patients who underwent SNM-I, 137 underwent permanent device implantation. A total of 76 (55%) and 61 (45%) patients reported 50%-75% (Group 1) and more than 75% (Group 2) symptomatic improvement, respectively. With a mean follow-up of 46 months, 44% of Group 1 patients and 68% of Group 2 patients still had a functioning device providing the symptomatic benefit (p = 0.007). Univariate analyses identified the presence of stress urinary incontinence at baseline and having a more than 75% improvement after SNM-I as predictors of long-term functional success. CONCLUSIONS Compared to patients reporting 50%-75% symptomatic reduction after SNM-I, individuals with a more than 75% improvement during SNM-I were more likely to maintain device efficacy over time. Additional study is warranted to determine if the improvement threshold for progression to SNM-II should be increased.
- Published
- 2021
- Full Text
- View/download PDF
5. Pain management following robotic-assisted radical prostatectomy: transitioning to an opioid free regimen
- Author
-
Zachary J. Prebay, Johnathan Doolittle, Robert Medairos, Jagan Kansal, Truman Landowski, Scott Johnson, Ross G. Everett, and Kenneth Jacobsohn
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,030232 urology & nephrology ,Health Informatics ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Robotic Surgical Procedures ,Internal medicine ,medicine ,Humans ,Pain Management ,Medical prescription ,Adverse effect ,Retrospective Studies ,Prostatectomy ,Pain, Postoperative ,business.industry ,Perioperative ,medicine.disease ,Analgesics, Opioid ,Regimen ,Opioid ,030220 oncology & carcinogenesis ,Cohort ,Surgery ,business ,medicine.drug - Abstract
Few studies demonstrate the safety and efficacy of postoperative pain regimens that exclude opioids altogether in patients undergoing robot-assisted radical prostatectomy (RARP). To reduce opioid use, we sought to develop an opioid-free regimen for RARP and determine perioperative outcomes before and after implementation. A retrospective, pre–post-interventional study was performed at a single institution between 8/2018 and 10/2019. An opioid-free pain regimen was developed and instituted on 3/7/2019, and all patients received preoperative counseling regarding pain expectations and management. Postoperative pain score was the primary outcome. Secondary outcomes included postoperative opioid use, length of stay, adverse events and unplanned health encounters within 30 days of discharge. Pearson’s chi-squared and Student’s t-tests were performed on categorical and continuous variables, respectively. Multivariable analysis was performed to determine risk factors for postoperative opioid use in the opioid-free cohort. A total of 89 patients were included for analysis; consisting of 47 (53%) pre-intervention and 42 (47%) post-intervention patients. Baseline characteristics were similar between groups. A significantly lower proportion of patients in the post-intervention group were administered opioids postoperatively (5% vs 53%, p
- Published
- 2021
- Full Text
- View/download PDF
6. Factors associated with recurrent urinary tract infections in spinal cord injured patients who use intermittent catheterization
- Author
-
Ross G, Everett, David K, Charles, Halle E, Foss, R Corey, O'Connor, and Michael L, Guralnick
- Subjects
Urinary Tract Infections ,Humans ,Female ,Intermittent Urethral Catheterization ,Urinary Bladder, Neurogenic ,Urinary Catheterization ,Spinal Cord Injuries ,Retrospective Studies - Abstract
Urinary Tract Infection (UTI) has been cited as the primary cause of morbidity in patients with history of spinal cord injury (SCI). Despite the significance of recurrent UTI (rUTI) in this population, the causative physiologic and patient characteristics are not well described. We sought to assess associations between demographic, clinical and urodynamic variables and rUTI.The records of 136 individuals with SCI who perform clean intermittent catheterization (CIC) were retrospectively reviewed. All had a video urodynamics study (VUDS) available for analysis. Individuals were divided into non-recurrent (3/year) or rUTI (≥ 3/year) groups. Differences between the cohorts were analyzed. Multivariable logistic regression was performed to determine associations between various demographic, clinical, and VUDS variables and rUTI.Self-reported rUTI were noted in 58 of 136 individuals. Of 124 individuals with urinary culture results, African American race (43.3% vs. 22.3%) and 'Other' race (13.3% vs. 8.5%) made up larger proportions in the rUTI group. Female gender (OR 4.96, 95% CI [1.44-17.13]) and African American race (OR 5.16, 95% CI [1.80-14.79]) were increasingly associated with rUTI on multivariable logistic regression. Shorter interval since injury was also significantly associated with recurrent infections with each year since injury indicating diminished likelihood (OR 0.91, 95% CI [0.82-0.99]). There were no significant differences in VUDS variables between groups and none were significant on regression as potential determinants of rUTI.Patient race, gender, and time since SCI appear to have significant associations with rUTI in individuals with SCI using CIC. However, VUDS variables were not found to be significantly associated with rUTI.
- Published
- 2021
7. PD16-12 IS CHEST IMAGING NEEDED AS PART OF T1A RENAL CELL CARCINOMA SURVEILLANCE AFTER SURGICAL RESECTION?
- Author
-
Scott Johnson, John Fitzgerald, Ross G. Everett, Peter Langenstroer, Brennen Cooper, Bill See, Kenneth Jacobsohn, Truman Landowski, Ray Yong, and David K. Charles
- Subjects
Surgical resection ,medicine.medical_specialty ,Lung ,Chest imaging ,business.industry ,Urology ,urologic and male genital diseases ,medicine.disease ,medicine.anatomical_structure ,Renal cell carcinoma ,medicine ,Surgical excision ,Radiology ,business - Abstract
INTRODUCTION AND OBJECTIVE:Following surgical excision of localized renal cell carcinoma (RCC), 20-30% will recur, with 50-60% being lung metastases. The NCCN and AUA guidelines recommend chest sur...
- Published
- 2021
- Full Text
- View/download PDF
8. MP48-10 DETERMINANTS OF RECURRENT URINARY TRACT INFECTION IN SPINAL CORD INJURY PATIENTS
- Author
-
R. Corey O'Connor, Ross G. Everett, Michael L. Guralnick, Michael A. Avallone, David K. Charles, and Halle Foss
- Subjects
medicine.medical_specialty ,business.industry ,Urology ,Internal medicine ,Urinary system ,Medicine ,In patient ,business ,medicine.disease ,Spinal cord injury - Abstract
INTRODUCTION AND OBJECTIVE:Urinary Tract Infection [UTI] has been cited as the primary cause of morbidity in patients with history of spinal cord injury [SCI]. Despite the high impact of recurrent ...
- Published
- 2020
- Full Text
- View/download PDF
9. MP66-17 CLINICAL EFFECTIVENESS OF BILATERAL ORCHIECTOMY IN REDUCING ANTI-ANDROGENS IN TRANSGENDER FEMALES
- Author
-
Bryce A. Toburen, Jay I. Sandlow, Kaylee M. Luck, and Ross G. Everett
- Subjects
Gender dysphoria ,genetic structures ,business.industry ,medicine.drug_class ,Clinical effectiveness ,Urology ,Anti-Androgen ,Physiology ,Testosterone (patch) ,Androgen ,medicine.disease ,Transgender ,Medicine ,business ,Bilateral orchiectomy - Abstract
INTRODUCTION AND OBJECTIVE:Androgen reducing medications are often given to suppress testosterone levels and reduce the dosage of exogenous estrogens in transwomen with gender dysphoria [GD]. Howev...
- Published
- 2020
- Full Text
- View/download PDF
10. PD32-12 ARE GENDER DYSPHORIA PATIENTS COUNSELED ON FERTILITY PRESERVATION PRIOR TO INITIATING HORMONAL THERAPY?
- Author
-
Johnathan Doolittle, Kaylee M. Luck, Tyler A. Wittmann, Ross G. Everett, Jay I. Sandlow, and Bryce A. Toburen
- Subjects
Gender dysphoria ,medicine.medical_specialty ,genetic structures ,Obstetrics ,business.industry ,Urology ,media_common.quotation_subject ,education ,Fertility ,medicine.disease ,behavioral disciplines and activities ,medicine ,Hormonal therapy ,Fertility preservation ,business ,media_common - Abstract
INTRODUCTION AND OBJECTIVE:Numerous national and international guidelines recommend counseling patients with gender dysphoria on the impacts of hormonal therapy on their fertility prior to beginnin...
- Published
- 2020
- Full Text
- View/download PDF
11. MP59-16 ROBOTIC VERSUS LAPAROSCOPIC RADICAL NEPHRECTOMY: A MATCHED PAIRED MULTICENTER ANALYSIS (ROSULA GROUP)
- Author
-
Jay Sulek, Robert G. Uzzo, David D. Y. Chen, Peter Langenstroer, Bo Yang, Alexandre Mottrie, Ahmet Bindayi, Umberto Capitanio, Sisto Perdonà, Giuseppe Simone, Monish Aron, Ithaar Derweesh, Luigi Schips, Wesley M. White, Chao Zang, Michael Liao, Ben Challacombe, Daniel Eun, Geert De Naeyer, Kidon Chang, Uzoma A. Anele, Prokar Dasgupta, Matteo Ferro, Alessandro Larcher, Andrea Minervini, Francesco Beradinelli, Stephen Ryan, Riccardo Autorino, Alexander Kutikov, Marco Carini, Riccardo Bertolo, Ross G. Everett, Andrea Mari, James Porter, Lance J. Hampton, Ken Jacobsohn, Chandru P. Sundaram, Patrick Kilday, Gabriele Tuderti, Koon Ho Rha, Nicolo de Luyk, Francesco Porpiglia, Peter Dietrich, M. Gallucci, Clayton Lau, Giuseppe Quarto, Francesco Montorsi, Marc C. Smaldone, and Manuela Constantini
- Subjects
medicine.medical_specialty ,Group (periodic table) ,business.industry ,Urology ,medicine ,Laparoscopic radical nephrectomy ,business ,Surgery - Published
- 2018
- Full Text
- View/download PDF
12. Long-term sexual health outcomes in men with classic bladder exstrophy
- Author
-
Ezekiel E. Young, John P. Gearhart, Heather N. Di Carlo, Cameron E. Alexander, Timothy S. Baumgartner, Pokket Sirisreetreerux, Nilay Gandhi, Sunil Reddy, Uzoma A. Anele, Ross G. Everett, Sarita Metzger, and Kathy Lue
- Subjects
Adult ,Male ,medicine.medical_specialty ,Epispadias ,Urology ,media_common.quotation_subject ,Sexual Behavior ,Population ,030232 urology & nephrology ,Fertility ,Andrology ,03 medical and health sciences ,Sexually active ,Young Adult ,0302 clinical medicine ,Surveys and Questionnaires ,medicine ,Humans ,Prospective Studies ,education ,Reproductive health ,media_common ,Azoospermia ,education.field_of_study ,030219 obstetrics & reproductive medicine ,business.industry ,Bladder Exstrophy ,Mean age ,medicine.disease ,Bladder exstrophy ,Semen Analysis ,Reproductive Health ,Family medicine ,Sex life ,business - Abstract
Objectives To identify the long-term sexual health outcomes and relationships in men born with classic bladder exstrophy (CBE). Materials and Methods A prospectively maintained institutional database comprising 1248 patients with exstrophy-epispadias was used. Men aged ≥18 years with CBE were included in the study. A 42-question survey was designed using a combination of demographic information and previously validated questionnaires. Results A total of 215 men met the inclusion criteria, of whom 113 (53%) completed the questionnaire. The mean age of the respondents was 32 years. Ninety-six (85%) of the respondents had been sexually active in their lifetime, and 66 of these (58%) were moderately to very satisfied with their sex life. The average Sexual Health Inventory for Men score was 19.8. All aspects of assessment using the Penile Perception Score questionnaire were on average between ‘very dissatisfied’ and ‘satisfied’. Thirty-two respondents (28%) had attempted to conceive with their partner. Twenty-three (20%) were successful in conceiving, while 31 (27%) reported a confirmed fertility problem. A total of 31 respondents (27%) reported undergoing a semen analysis or post-ejaculatory urine analysis. Of these, only four respondents reported azoospermia. Conclusion Patients with CBE have many of the same sexual and relationship successes and concerns as the general population. This is invaluable information to give to both the parents of boys with CBE, and to the boys themselves as they transition to adulthood.
- Published
- 2017
13. Are gender dysphoria patients counseled on fertility preservation prior to initiating hormonal therapy?
- Author
-
Jay I. Sandlow, Kaylee M. Luck, Ross G. Everett, Bryce A. Toburen, and Johnathan Doolittle
- Subjects
Gender dysphoria ,medicine.medical_specialty ,Reproductive Medicine ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Medicine ,Hormonal therapy ,Fertility preservation ,business ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
14. Patient-Reported Impact of Pelvic Organ Prolapse on Continence and Sexual Function in Women With Exstrophy-Epispadias Complex
- Author
-
Edward James Wright, Ezekiel E. Young, Mahmoud Abdelwahab, Cameron E. Alexander, D. Friedlander, Kathy M. Lue, Sunil Reddy, John P. Gearhart, Ross G. Everett, and Nilay M. Gandhi
- Subjects
Adult ,medicine.medical_specialty ,Epispadias ,genetic structures ,Urology ,030232 urology & nephrology ,Urinary incontinence ,Severity of Illness Index ,Pelvic Organ Prolapse ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Quality of life ,Severity of illness ,medicine ,Humans ,Abnormalities, Multiple ,Longitudinal Studies ,Patient Reported Outcome Measures ,Retrospective Studies ,Gynecology ,030219 obstetrics & reproductive medicine ,Urinary continence ,business.industry ,General surgery ,Bladder Exstrophy ,Obstetrics and Gynecology ,Middle Aged ,Plastic Surgery Procedures ,medicine.disease ,Bladder exstrophy ,Sexual Dysfunction, Physiological ,Sexual dysfunction ,Urinary Incontinence ,Quality of Life ,Surgery ,Female ,medicine.symptom ,Sexual function ,business - Abstract
Objective This study aimed to characterize long-term urogynecologic issues of women with a history of bladder exstrophy and pelvic organ prolapse (POP) and to assess the impact of POP repair on continence and sexual function. Design Patient demographics and surgical history related to exstrophy and POP were collected through chart review. Patient perceptions regarding sexual function, urinary continence, and quality of life were assessed through Web-based administration of validated questionnaires: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form and POP-Urinary Incontinence Sexual Questionnaire. Setting Maryland, United States. Participants Review of a single-institution exstrophy-epispadias complex database resulted in 25 adult female patients with a history of POP treated at the authors' institution. Eleven patients participated and were included in the analysis. Main outcome measures Urinary continence and sexual function. Results All participants underwent surgical repair for prolapse, with 7 (63.6%) experiencing unsuccessful initial repair and subsequent recurrence. Median total number of POP repairs was 2.5 (1-4). After correction of POP, patients reported a median improvement in International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form scores of 11 (21 to -1) of 21 and in POP-Urinary Incontinence Sexual Questionnaire scores of 9.5 (6.5-33.0) of 48.0. With regard to urinary continence, 6 (54.5%) patients presently reported no incontinence, 3 (27.3%) reported mild incontinence, and 2 (18.2%) reported continuous incontinence. Conclusions Pelvic organ prolapse poses significant reductions in quality of life for women born with exstrophy, with effects on urinary continence and sexual function. Identification and correction of prolapse seems to result in notable improvements in the lives of these patients.
- Published
- 2017
15. MP81-12 LONG-TERM SEXUAL HEALTH OUTCOMES IN MEN WITH CLASSIC BLADDER EXSTROPHY
- Author
-
Sunil Reddy, John P. Gearhart, Kathy Lue, Timothy S. Baumgartner, Nilay Gandhi, Uzoma A. Anele, Heather N. Di Carlo, Ross G. Everett, Cameron E. Alexander, and Ezekiel E. Young
- Subjects
Gynecology ,Bladder exstrophy ,Pediatrics ,medicine.medical_specialty ,business.industry ,Urology ,medicine ,business ,medicine.disease ,Reproductive health ,Term (time) - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.